Anzeige
Mehr »
Login
Mittwoch, 01.05.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Uran Boom: Die Bullen starten durch - spektakuläre Kursgewinne möglich
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PUQT | ISIN: DK0061155009 | Ticker-Symbol:
1-Jahres-Chart
PHARMA EQUITY GROUP A/S Chart 1 Jahr
5-Tage-Chart
PHARMA EQUITY GROUP A/S 5-Tage-Chart

Aktuelle News zur PHARMA EQUITY GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
23.04.Major shareholder announcement - Pharma Equity Group A/S1
16.04.Passing of the General Meeting of Pharma Equity Group A/S1
10.04.Pharma Equity Group A/S: The Board of Director's decision to issue convertible loans1
05.04.Pharma Equity Group A/S: Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, reports highly positive final results from the phase-2 clinical trial of the company's patented drug candidate RNX-051.695 April 2024 Company Announcement No. 11 Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, reports highly positive final results from the phase-2 clinical trial of the company's patented...
► Artikel lesen
25.03.Notice convening the annual general meeting in Pharma Equity Group A/S1
22.03.Pharma Equity Group A/S (PEG) enters into an agreement with Danske Bank on the exercise of market maker in the PEG share, fund code: DK006115500936Date: 22 March 2024 Announcement of the Year No. 9 Pharma Equity Group A/S (PEG) enters into an agreement with Danske Bank on the exercise of market maker in the PEG share, fund code: DK0061155009...
► Artikel lesen
21.03.Pharma Equity Group A/S: Completion of subscription of convertible loans1
20.03.Pharma Equity Group A/S - Annual Report 202373Pharma Equity Group A/S - Annual Report 2023 Date: March 20, 2024Announcement of the Year No.: 7 Pharma Equity Group A/S - Annual report 2023 - main features of the year Today, the Board of Directors...
► Artikel lesen
05.03.Pharma Equity Group A/S: Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has received notification from the European Patent Office (EPO) regarding the decision to grant their patent for drug compositions for promoting the healing of wounds119Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has received notification from the European Patent Office (EPO) regarding the decision to grant their patent for drug compositions for...
► Artikel lesen
07.02.Pharma Equity Group A/S: Completion of subscription of convertible loans-
07.02.Pharma Equity Group A/S: The Board of Director's decision to issue convertible loans-
25.01.Pharma Equity Group A/S: Completion of subscription of convertible loans1
22.01.Pharma Equity Group A/S: Notification from the European Patent Office (EPO) regarding the decision to grant their patent for drug compositions aiming to eliminate bacterial promoters of colorectal cancer through intraluminal application (RNX-051).148Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has received notification from the European Patent Office (EPO) regarding the decision to grant their patent for drug compositions aiming...
► Artikel lesen
22.01.Pharma Equity Group A/S: The Board of Director's decision to issue convertible loans1
28.11.23Pharma Equity Group A/S: Status of the Company's receivable from Portinho S.A.1
28.11.23Pharma Equity Group A/S: 2024 Financial Calendar1
16.11.23Pharma Equity Group A/S: Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) meets the primary endpoints in the phase-2 clinical trial of the drug candidate RNX-051.2
16.11.23Pharma Equity Group A/S: Consolidated interim report 1 January - 30 September 2023157Consolidated interim report 1 January - 30 September 2023 16 November 2023 Company Announcement no. 44 Key points (nine-month report ended 30 September 2023) On 16 November 2023, the Board of Directors...
► Artikel lesen
02.11.23Resolutions of the Extraordinary General Meeting of Pharma Equity Group A/S1942 November 2023 Announcement no. 43 Resolutions of the Extraordinary General Meeting of Pharma Equity Group A/S Pharma Equity Group A/S today held its Extraordinary General Meeting with the...
► Artikel lesen
31.10.23Pharma Equity Group A/S: Pharma Equity Group's subsidiary company (Reponex Pharmaceuticals A/S) have received grant of US Patent for a method of treatment on its topical wound-healing composition.13831 October 2023 Announcement no. 41 Pharma Equity Group's subsidiary company (Reponex Pharmaceuticals A/S) have received grant of US Patent for a method of treatment on its topical wound-healing composition....
► Artikel lesen
Seite:  Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1